SEARCH
Search Details
Tanaka Toshimitsu
Cancer Multidisciplinary Treatment Center
Assistant Professor
Research activity information
■ Award
■ Paper
■ Paper
- Nutritional indices are potentially important prognostic biomarkers before chemotherapy for non-specific subsets of cancer of unknown primary origin.
Shotaro Yamaguchi; Toshimitsu Tanaka; Sachiko Nagasu; Masaru Fukahori; Yasutaka Shimotsuura; Fumihiko Fujita; Kenta Murotani; Takumi Kawaguchi; Keisuke Miwa
Molecular and clinical oncology, Mar. 2026
Corresponding - Efficacy of third-line chemotherapy following nanoliposomal irinotecan combined with fluorouracil and folinic acid as second-line treatment for unresectable pancreatic cancer
Keisuke Miwa; Reina Kawasaki; Mototsugu Shimokawa; Taiga Otsuka; Toshimitsu Tanaka; Masaru Fukahori; Taro Shibuki; Junichi Nakazawa; Shiho Arima; Futa Koga; Yujiro Ueda; Yoshihito Kubotsu; Hozumi Shimokawa; Shigeyuki Takeshita; Kazuo Nishikawa; Azusa Komori; Satoshi Otsu; Ayumu Hosokawa; Tatsunori Sakai; Hisanobu Oda; Machiko Kawahira; Shuji Arita; Takuya Honda; Hiroki Taguchi; Kengo Tsuneyoshi; Toshihiro Fujita; Takahiro Sakae; Yasunori Kawaguchi; Tsuyoshi Shirakawa; Toshihiko Mizuta; Kenji Mitsugi
FRONTIERS IN ONCOLOGY, 17 Jul. 2025 - 【新たな疾患定義で広がる脂肪性肝疾患診療】疫学 MASLD/MetALDの臨床像
鈴木 浩之; 堤 翼; 田中 俊光; 福永 秀平; 中野 暖; 川口 真知子; 戸次 鎮宗; 天野 恵介; 中野 聖士; 川口 巧
肝胆膵, Mar. 2025 - Case Report: Catheter rupture of central venous port devices placed via the right internal jugular vein for chemotherapy in gastrointestinal cancer patients: a four-case series.
Toshimitsu Tanaka; Fukahori Masaru; Sachiko Nagasu; Asako Kuhara; Masamichi Koganemaru; Shuichi Tanoue; Fumihiko Fujita; Takumi Kawaguchi; Keisuke Miwa
Frontiers in oncology, 2025
Lead - A Rare Case of Primary Hepatic Undifferentiated Pleomorphic Sarcoma: Exploring Cancer-related Gene Mutations.
Hiroyuki Suzuki; Michitaka Fukuda; Tomotake Shirono; Reiichiro Kondo; Toshimitsu Tanaka; Takashi Niizeki; Jun Akiba; Hironori Koga; Takumi Kawaguchi
Internal medicine (Tokyo, Japan), 08 Nov. 2024 - 化学療法前の原発不明癌では栄養指標が重要な予後予測におけるバイオマーカーとなる
山口 翔太郎; 田中 俊光; 長主 祥子; 下津浦 康隆; 藤田 文彦; 室谷 健太; 川口 巧; 三輪 啓介
日本癌治療学会学術集会抄録集, Oct. 2024 - Efficacy of timing‑dependent infusion of nivolumab in patients with advanced gastric cancer.
Toshimitsu Tanaka; Hiroyuki Suzuki; Shotaro Yamaguchi; Yasutaka Shimotsuura; Sachiko Nagasu; Kenta Murotani; Fumihiko Fujita; Takumi Kawaguchi; Keisuke Miwa
Oncology letters, Oct. 2024
Lead - Ex-vivo expanded CD34+ cell transplantation alleviates fibrotic liver injury via innate immune modulation in metabolic dysfunction-associated steatohepatitis mice.
Atsutaka Masuda; Toru Nakamura; Hideki Iwamoto; Hiroyuki Suzuki; Takahiko Sakaue; Toshimitsu Tanaka; Yasuko Imamura; Nobuyuki Mori; Hironori Koga; Takumi Kawaguchi
Cytotherapy, Aug. 2024 - Anti-PD-L1 antibodies promote cellular proliferation by activating the PD-L1-AXL signal relay in liver cancer cells.
Toshimitsu Tanaka; Hironori Koga; Hiroyuki Suzuki; Hideki Iwamoto; Takahiko Sakaue; Atsutaka Masuda; Toru Nakamura; Jun Akiba; Hirohisa Yano; Takuji Torimura; Takumi Kawaguchi
Hepatology international, Jun. 2024
Lead - Fibroblast growth factor inhibition by molecular-targeted agents mitigates immunosuppressive tissue microenvironment in hepatocellular carcinoma.
Hiroyuki Suzuki; Hideki Iwamoto; Toshimitsu Tanaka; Takahiko Sakaue; Yasuko Imamura; Atsutaka Masuda; Toru Nakamura; Hironori Koga; Yujin Hoshida; Takumi Kawaguchi
Hepatology international, Apr. 2024 - Changing from NAFLD to MASLD: Similar prognosis of unresectable extrahepatic gastrointestinal cancer under chemotherapy between NAFLD and MASLD.
Hiroyuki Suzuki; Toshimitsu Tanaka; Shotaro Yamaguchi; Keisuke Miwa; Takumi Kawaguchi
Journal of hepatology, Apr. 2024
Corresponding - A tumor endothelial cell-specific microRNA replacement therapy for hepatocellular carcinoma.
Hideki Iwamoto; Hiroyuki Suzuki; Atsutaka Masuda; Takahiko Sakaue; Toru Nakamura; Toshimitsu Tanaka; Miwa Sakai; Yasuko Imamura; Hirohisa Yano; Takuji Torimura; Hironori Koga; Kaori Yasuda; Masakatsu Tsurusaki; Takahiro Seki; Takumi Kawaguchi
iScience, 16 Feb. 2024 - Patient Satisfaction Survey on Portable Infusion Pumps for Colorectal Cancer Chemotherapy: Hard-Shelled or Soft-Shelled?
Taku Yamada; Taketomo Kikuchi; Sachiko Nagasu; Kayoko Hashimoto; Eri Furukawa; Hirokazu Matsumoto; Kazuki Tsutsumi; Toshimitsu Tanaka; Miho Kugishima; Takumi Kawaguchi; Fumihiko Fujita; Kyouko Higuchi; Keisuke Miwa
Patient preference and adherence, 2024 - Pancreatic Juice-Derived microRNA-4516 and microRNA-4674 as Novel Biomarkers for Pancreatic Ductal Adenocarcinoma.
Takahiko Sakaue; Hironori Koga; Hideki Iwamoto; Toru Nakamura; Atsutaka Masuda; Toshimitsu Tanaka; Hiroyuki Suzuki; Hideya Suga; Shingo Hirai; Toru Hisaka; Yoshiki Naito; Keisuke Ohta; Kei-Ichiro Nakamura; Karuppaiyah Selvendiran; Yoshinobu Okabe; Takuji Torimura; Takumi Kawaguchi
Gastro hep advances, 2024 - High intramuscular adipose tissue content was a favorable prognostic factor in patients with advanced gastric cancer treated with nivolumab monotherapy.
Toshimitsu Tanaka; Keisuke Miwa; Yasutaka Shimotsuura; Sachiko Nagasu; Hirona Shigyou; Keisuke Hirota; Shunji Koya; Yoshito Akagi; Takumi Kawaguchi
Journal of gastroenterology and hepatology, Oct. 2023
Lead, Corresponding - Safety of Early Bevacizumab Administration after Central Venous Port Placement for Patients with Colorectal Cancer.
Hirona Shigyo; Hiroyuki Suzuki; Toshimitsu Tanaka; Etsuko Moriyama; Yasutaka Shimotsuura; Sachiko Nagasu; Hideki Iwamoto; Yoshito Akagi; Kenta Murotani; Takumi Kawaguchi; Keisuke Miwa
Cancers, 12 Apr. 2023
Corresponding - Tumor-derived insulin-like growth factor-binding protein-1 contributes to resistance of hepatocellular carcinoma to tyrosine kinase inhibitors.
Hiroyuki Suzuki; Hideki Iwamoto; Takahiro Seki; Toru Nakamura; Atsutaka Masuda; Takahiko Sakaue; Toshimitsu Tanaka; Yasuko Imamura; Takashi Niizeki; Masahito Nakano; Shigeo Shimose; Tomotake Shirono; Yu Noda; Naoki Kamachi; Miwa Sakai; Kazutoyo Morita; Masamichi Nakayama; Tomoharu Yoshizumi; Ryoko Kuromatsu; Hirohisa Yano; Yihai Cao; Hironori Koga; Takuji Torimura
Cancer communications (London, England), Apr. 2023 - T-cell factor-4 variants regulate PD-L1 expression in liver cancer cells
TOSHIMITSU TANAKA
Cancer Research, 2023 - Evaluation of the nematode C. elegans cancer test (N-NOSE) in thyroid cancer
TOSHIMITSU TANAKA
Annals of Oncology, 2023 - Early monocyte elevation after atezolizumab plus bevacizumab therapy could be a therapeutic biomarker in HCC
TOSHIMITSU TANAKA
Cancer Science, 2023 - A case of complete response to entrectinib in NTRK fusion gene-positive parotid carcinoma
TOSHIMITSU TANAKA
Annals of Oncology, 2023 - Case Report: A case of complete response to entrectinib in NTRK fusion gene-positive parotid gland cancer.
Etsuko Moriyama; Sachiko Nagasu; Toshimitsu Tanaka; Yasutaka Shimotsuura; Takeharu Ono; Hirohito Umeno; Jun Akiba; Akihiko Kawahara; Fumihiko Fujita; Takumi Kawaguchi; Keisuke Miwa
Frontiers in oncology, 2023 - Case report: A case of fulminant type 1 diabetes mellitus after COVID-19 vaccination during treatment of advanced gastric cancer: pitfall in managing immune-related adverse events.
Toshimitsu Tanaka; Sachiko Nagasu; Takuya Furuta; Mizuki Gobaru; Hiroyuki Suzuki; Yasutaka Shimotsuura; Jun Akiba; Masatoshi Nomura; Fumihiko Fujita; Takumi Kawaguchi; Keisuke Miwa
Frontiers in oncology, 2023
Lead - Hyperlipidemia as a risk factor for Trousseau syndrome-related cerebral infarction in patients with advanced gastrointestinal cancer.
Toshimitsu Tanaka; Hiroyuki Suzuki; Keisuke Miwa; Tomoyuki Ushijima; Sachiko Nagasu; Masaru Fukahori; Kaito Ishii; Toru Nakamura; Hideki Iwamoto; Atsutaka Masuda; Takahiko Sakaue; Hironori Koga; Yoshito Akagi; Kenta Murotani; Takuji Torimura
Oncology letters, Sep. 2022
Lead - 抗PD-L1抗体による肝癌細胞増殖機構の解明
田中 俊光; 古賀 浩徳; 鈴木 浩之; 岩本 英希; 阪上 尊彦; 増田 篤高; 中村 徹; 秋葉 純; 矢野 博久; 鳥村 拓司
日本消化器病学会雑誌, Mar. 2022 - NOVEL EXOSOMAL MICRORNAS SPECIFIC FOR PANCREATIC DUCTAL ADENOCARCINOMA IDENTIFIED FROM PANCREATIC JUICE
TOSHIMITSU TANAKA
Gastroenterology, 2022 - DNA Methylation in Noncancerous Liver Tissues as Biomarker for Multicentric Occurrence of Hepatitis C Virus-Related Hepatocellular Carcinoma.
Hiroyuki Suzuki; Hideki Iwamoto; Ken Yamamoto; Mai Tsukaguchi; Toru Nakamura; Atsutaka Masuda; Takahiko Sakaue; Toshimitsu Tanaka; Takashi Niizeki; Shusuke Okamura; Shigeo Shimose; Tomotake Shirono; Yu Noda; Naoki Kamachi; Ryoko Kuromatsu; Toru Hisaka; Hirohisa Yano; Hironori Koga; Takuji Torimura
Gastro hep advances, 2022 - Case report: Changes in serum bevacizumab concentration in a hemodialysis patient with unresectable colorectal cancer treated with FOLFIRI plus bevacizumab.
Toshimitsu Tanaka; Hiroyuki Suzuki; Tomoyuki Ushijima; Sachiko Nagasu; Yoshito Akagi; Takumi Kawaguchi; Keisuke Miwa
Frontiers in oncology, 2022
Lead - Efficacy and tolerability of Sorafenib plus metronomic chemotherapy S-1 for advanced hepatocellular carcinoma in preclinical and clinical assessments.
Hiroyuki Suzuki; Hideki Iwamoto; Masahito Nakano; Toru Nakamura; Atsutaka Masuda; Takahiko Sakaue; Toshimitsu Tanaka; Dan Nakano; Ryoko Kuromatsu; Takashi Niizeki; Shusuke Okamura; Shigeo Shimose; Tomotake Shirono; Yu Noda; Naoki Kamachi; Hirohisa Yano; Atsushi Kawaguchi; Hironori Koga; Takuji Torimura
Translational oncology, Nov. 2021 - A phase II study of gemcitabine plus nab-paclitaxel as first-line therapy for locally advanced pancreatic cancer.
Masaru Fukahori; Keisuke Miwa; Kenta Murotani; Yoshiki Naito; Tomoyuki Ushijima; Takahiko Sakaue; Toshimitsu Tanaka; Sachiko Nagasu; Hideya Suga; Tatsuyuki Kakuma; Yoshinobu Okabe; Takuji Torimura
Medicine, 21 May 2021 - QOL改善を目指した自家末梢血CD34陽性細胞移植による肝硬変治療開発
中村 徹; 増田 篤高; 岩本 英希; 鈴木 浩之; 田中 俊光; 阪上 尊彦; 古賀 浩徳; 鳥村 拓司
肝臓, Apr. 2021 - FGFR INHIBITION ALTERS 'COLD TUMOR' INTO 'HOT TUMOR' IN IMMUNE SYNGENEIC ORTHOTOPIC HEPATOCELLULAR CARCINOMA
TOSHIMITSU TANAKA
Hepatology, 2021 - Elevated serum IGFBP-1 levels after lenvatinib treatment reflect intratumoral ischemia
TOSHIMITSU TANAKA
Cancer Science, 2021 - Anti-PD-L1 antibodies promote proliferation of sarcomatous liver cancer cells
TOSHIMITSU TANAKA
Cancer Science, 2021 - Precise evaluation of TCF-4 isoform expressions in tumors derived from digestive organs
TOSHIMITSU TANAKA
Cancer Science, 2021 - Character Input Method Working on 1-in. Round Screen for Tiny Smartwatches
TOSHIMITSU TANAKA
Lecture Notes in Computer Science, 2021 - レンバチニブ投与により上昇する血清IGFBP-1は腫瘍内虚血を反映する
鈴木 浩之; 岩本 英希; 阪上 尊彦; 田中 俊光; 古賀 浩徳; 鳥村 拓司
日本癌学会総会記事, Oct. 2020 - 切除不能局所進行膵癌に対するGemcitabine+nab-Paclitaxel療法の単施設第II相試験
深堀 理; 牛島 知之; 岡部 義信; 重藤 宏太; 田中 俊光; 長主 祥子; 阪上 尊彦; 島松 裕; 安元 真希子; 三輪 啓介; 鶴田 修; 鳥村 拓司
日本消化器病学会雑誌, Oct. 2020 - Promotion of liver regeneration and anti‑fibrotic effects of the TGF‑β receptor kinase inhibitor galunisertib in CCl4‑treated mice.
Atsutaka Masuda; Toru Nakamura; Mitsuhiko Abe; Hideki Iwamoto; Takahiko Sakaue; Toshimitsu Tanaka; Hiroyuki Suzuki; Hironori Koga; Takuji Torimura
International journal of molecular medicine, Jul. 2020 - Profiles Combining Muscle Atrophy and Neutrophil-to-Lymphocyte Ratio Are Associated with Prognosis of Patients with Stage IV Gastric Cancer.
Kota Shigeto; Takumi Kawaguchi; Shunji Koya; Keisuke Hirota; Toshimitsu Tanaka; Sachiko Nagasu; Masaru Fukahori; Tomoyuki Ushijima; Hiroo Matsuse; Keisuke Miwa; Koji Nagafuji; Takuji Torimura
Nutrients, 24 Jun. 2020 - Weekends-Off Lenvatinib for Unresectable Hepatocellular Carcinoma Improves Therapeutic Response and Tolerability toward Adverse Events.
Hideki Iwamoto; Hiroyuki Suzuki; Shigeo Shimose; Takashi Niizeki; Masahito Nakano; Tomotake Shirono; Shusuke Okamura; Yu Noda; Naoki Kamachi; Toru Nakamura; Atsutaka Masuda; Takahiko Sakaue; Toshimitsu Tanaka; Dan Nakano; Miwa Sakai; Taizo Yamaguchi; Ryoko Kuromatsu; Hironori Koga; Takuji Torimura
Cancers, 19 Apr. 2020 - レンバチニブは腫瘍免疫微小環境を免疫学的'cold'から'hot'へ変化させる
鈴木 浩之; 岩本 英希; 中村 徹; 増田 篤高; 阪上 尊彦; 田中 俊光; 中野 暖; 古賀 浩徳; 鳥村 拓司
肝臓, Apr. 2020 - Pancreatic juice biomarker for detection of early stage pancreatic cancer using tumor-specific exosomal microRNAs
TOSHIMITSU TANAKA
Cancer Research, 2020 - Opposite functions of Claudin-2 involving Wnt signaling in liver cancer cells
TOSHIMITSU TANAKA
Cancer Research, 2020 - Glycosylation of ascites-derived exosomal CD133: a potential prognostic biomarker in patients with advanced pancreatic cancer.
Takahiko Sakaue; Hironori Koga; Hideki Iwamoto; Toru Nakamura; Yu Ikezono; Mitsuhiko Abe; Fumitaka Wada; Atsutaka Masuda; Toshimitsu Tanaka; Masaru Fukahori; Tomoyuki Ushijima; Yuutarou Mihara; Yoshiki Naitou; Yoshinobu Okabe; Tatsuyuki Kakuma; Keisuke Ohta; Kei-Ichiro Nakamura; Takuji Torimura
Medical molecular morphology, Dec. 2019 - [A Case of Chemotherapy-Induced Hyperammonemic Encephalopathy in a Patient with Metastatic Colon Cancer].
Toshimitsu Tanaka; Keisuke Miwa; Masaru Fukahori; Takatou Yomoda; Takahiko Sakaue; Sachiko Nagasu; Tomoyuki Ushijima; Hironori Koga; Takuji Torimura
Gan to kagaku ryoho. Cancer & chemotherapy, Feb. 2019
Lead - 【大腸内分泌細胞腫瘍-WHOの考え方と日本の考え方】大腸内分泌細胞腫瘍の薬物療法
深堀 理; 三輪 啓介; 長主 祥子; 下津浦 康隆; 田中 俊光; 牛島 知之; 阪上 尊彦; 岡部 義信; 鶴田 修
Intestine, Jan. 2019 - Experience of lenvatinib therapy for patients with differentiated thyroid cancer in our hospital
TOSHIMITSU TANAKA
Annals of Oncology, 2019 - CD34-POSITIVE CELL TRANSPLANTATION IMPROVES LIVER FIBROSIS IN A MOUSE MODEL OF NON-ALCOHOLIC STEATOHEPATITIS
TOSHIMITSU TANAKA
Hepatology, 2019 - INVOLVEMENT OF WNT SIGNALING IN TWO-FACED ACTIONS OF CLAUDIN-2 IN LIVER CANCER CELLS
TOSHIMITSU TANAKA
Hepatology, 2019 - 癌性腹水由来exosome中CD133に対する糖鎖修飾が進行膵癌患者の予後予測のバイオマーカーとなり得る
阪上 尊彦; 古賀 浩徳; 岩本 英希; 中村 徹; 安倍 満彦; 和田 史孝; 増田 篤高; 田中 俊光; 深堀 理; 牛島 知之; 岡部 義信; 鳥村 拓司
日本消化器病学会雑誌, Oct. 2018 - High expression of CD44v9 and xCT in chemoresistant hepatocellular carcinoma: Potential targets by sulfasalazine.
Fumitaka Wada; Hironori Koga; Jun Akiba; Takashi Niizeki; Hideki Iwamoto; Yu Ikezono; Toru Nakamura; Mitsuhiko Abe; Atsutaka Masuda; Takahiko Sakaue; Toshimitsu Tanaka; Tatsuyuki Kakuma; Hirohisa Yano; Takuji Torimura
Cancer science, Sep. 2018 - The Wnt target gene CLAUDIN-2 regulates tumorigenesis and stemness in human liver cancer cells
TOSHIMITSU TANAKA
Cancer Research, 2018 - HES1 critically regulates sphere-forming ability and tumorigenesis in WNT signal-engineered liver cancer cells
TOSHIMITSU TANAKA
Cancer Science, 2018 - Proteomic Discovery of Brain-Derived Neurotrophic Factor in Serum and Bile Ducts in Cholestasis
TOSHIMITSU TANAKA
Hepatology, 2018 - CD44v9 expression in surviving liver cancer cells treated with hepatic arterial infusion chemoembolization therapy
TOSHIMITSU TANAKA
Cancer Science, 2018 - Claudin-2 Activates LKB1-AMPK Signals, Thereby Inducing Cell-Cycle Arrest and Autophagy in Liver Cancer Cells
古賀 浩徳; 和田 史孝; 阪上 尊彦; 岩本 英希; 安倍 満彦; 鳥村 拓司
Hepatology, 2018 - STAT3 deficiency prevents hepatocarcinogenesis and promotes biliary proliferation in thioacetamide-induced liver injury.
Mitsuhiko Abe; Takafumi Yoshida; Jun Akiba; Yu Ikezono; Fumitaka Wada; Atsutaka Masuda; Takahiko Sakaue; Toshimitsu Tanaka; Hideki Iwamoto; Toru Nakamura; Michio Sata; Hironori Koga; Akihiko Yoshimura; Takuji Torimura
World journal of gastroenterology, 07 Oct. 2017 - 肝動注化学塞栓療法後に残存した肝細胞癌におけるCD44v9の発現の検討
和田 史孝; 古賀 浩徳; 秋葉 純; 池園 友; 中村 徹; 安倍 満彦; 岩本 英希; 阪上 尊彦; 増田 篤高; 田中 俊光; 矢野 博久; 鳥村 拓司
日本癌学会総会記事, Sep. 2017 - HES1はWNTシグナル改変肝癌細胞においてスフィア形成能や造腫瘍能を決定的に制御する
古賀 浩徳; 中村 徹; 和田 史孝; 岩本 英希; 増田 篤高; 阪上 尊彦; 田中 俊光; 安倍 満彦; 秋葉 純; 矢野 博久; 鳥村 拓司
日本癌学会総会記事, Sep. 2017 - 膵癌癌性腹水由来エクソソームに内在するCD133糖鎖の臨床的意義
阪上 尊彦; 古賀 浩徳; 中村 徹; 池園 友; 和田 史孝; 安倍 満彦; 岩本 英希; 増田 篤高; 田中 俊光; 深堀 理; 岡部 義信; 鳥村 拓司
日本消化器病学会雑誌, Sep. 2017 - The Wnt Target Gene CLAUDIN-2 Regulates Tumorigenesis of Combined Hepatocellular-Cholangiocarcinoma Cells
TOSHIMITSU TANAKA
Hepatology, 2017 - Targeting CD44v9-xCT system by sulfasalazine to overcome cisplatin resistance in human liver cancer cells
TOSHIMITSU TANAKA
Hepatology, 2017 - Long term outcome of autologous G-CSF mobilized PB-CD34+ cell therapy in patients with decompensated liver cirrhosis
TOSHIMITSU TANAKA
Hepatology, 2016 - The Wnt effector T-CELL FACTOR-4 isoform activates Notch signaling via upregulating CLAUDIN-2 in human liver cancer cells
TOSHIMITSU TANAKA
Hepatology, 2016 - Decreased serum levels of immunoglobulin A, immunoglobulin M and immunoglobulin G in a patient with primary biliary cirrhosis: A case report.
Takumi Kawaguchi; Toshimitsu Tanaka; Michitoshi Hashiguchi; Hiroaki Miyoshi; Jun Akiba; Masayoshi Kage; Hirohisa Yano; Koichi Ohshima; Takashi Okamura; Michio Sata
Hepatology research : the official journal of the Japan Society of Hepatology, Oct. 2014
- 進行胃癌患者におけるニボルマブ療法の投与開始時刻と予後の関連
田中俊光; 田中俊光; 三輪啓介; 三輪啓介; 長主祥子; 長主祥子; 深堀理; 深堀理; 藤田文彦; 川口巧
日本消化器病学会雑誌(Web), 2025 - 化学療法前の原発不明癌では栄養指標が重要な予後予測におけるバイオマーカーとなる
山口 翔太郎; 田中 俊光; 長主 祥子; 下津浦 康隆; 藤田 文彦; 室谷 健太; 川口 巧; 三輪 啓介
日本癌治療学会学術集会抄録集, Oct. 2024 - 【MASLD/MASH-脂肪性肝疾患の新概念-】疾患概念オーバービュー MASLD/MASHとは?
鈴木 浩之; 堤 翼; 佐野 有哉; 天野 恵介; 中野 暖; 福永 秀平; 田中 俊光; 中野 聖士; 川口 巧
肝臓クリニカルアップデート, Jun. 2024 - 進行大腸癌患者における中心静脈ポート留置後の早期ベバシズマブ投与の安全性の検討
田中俊光; 田中俊光; 三輪啓介; 三輪啓介; 長主祥子; 長主祥子; 山口翔太郎; 山口翔太郎; 藤田文彦; 川口巧
日本消化器病学会雑誌(Web), 2024 - 化学療法中の肝外消化管癌患者におけるMASLDの有病率と予後の検討
田中俊光; 田中俊光; 三輪啓介; 三輪啓介; 長主祥子; 長主祥子; 深堀理; 深堀理; 山口翔太郎; 山口翔太郎; 藤田文彦; 川口巧
日本癌治療学会学術集会(Web), 2024 - Nivolumabの時間依存性有効性:胃がん患者を対象とした後ろ向き試験の結果
田中俊光; 田中俊光; 三輪啓介; 三輪啓介; 長主祥子; 長主祥子; 下津浦康隆; 下津浦康隆; 赤木由人; 川口巧
日本癌治療学会学術集会(Web), 2023 - 抗PD-L1抗体は肝癌細胞の増殖を促進しうる
田中俊光; 古賀浩徳; 鈴木浩之; 岩本英希; 阪上尊彦; 増田篤高; 中村徹; 田中俊光; 古賀浩徳; 鈴木浩之; 岩本英希; 阪上尊彦; 増田篤高; 中村徹; 秋葉純; 矢野博久; 川口巧
日本臨床分子形態学会総会・学術集会講演プログラム・要旨集, 2023 - 抗PD-L1抗体による肝癌細胞増殖機構の解明
田中俊光; 田中俊光; 古賀浩徳; 古賀浩徳; 鈴木浩之; 鈴木浩之; 岩本英希; 岩本英希; 阪上尊彦; 阪上尊彦; 増田篤高; 増田篤高; 中村徹; 中村徹; 秋葉純; 矢野博久; 鳥村拓司
日本消化器病学会雑誌(Web), 2022 - 進行胃癌患者に対するニボルマブ療法における予後因子の検討
田中俊光; 田中俊光; 三輪啓介; 三輪啓介; 長主祥子; 長主祥子; 牛島知之; 牛島知之; 赤木由人; 鳥村拓司
日本消化器病学会雑誌(Web), 2022 - 進行胃癌患者に対するニボルマブ療法におけるがん悪液質とリンパ球数の予後への影響
田中俊光; 田中俊光; 三輪啓介; 三輪啓介; 長主祥子; 長主祥子; 牛島知之; 牛島知之; 赤木由人; 川口巧
日本癌治療学会学術集会(Web), 2022 - 切除不能大腸癌患者に対するBevacizumab治療症例での皮下埋め込み型中心静脈カテーテル用ポート留置術後の合併症の検討
田中俊光; 三輪啓介; 長主祥子; 下津浦康隆; 執行ひろな; 田中俊光; 三輪啓介; 長主祥子; 下津浦康隆; 執行ひろな; 赤木由人; 川口巧
リザーバー&ポート研究会プログラム・抄録集, 2022 - 切除不能進行胃癌患者で3次治療以降にニボルマブ単独療法で発症した免疫関連有害事象(irAE)と予後の解析
田中俊光; 田中俊光; 三輪啓介; 三輪啓介; 梶原彰; 梶原彰; 長主祥子; 長主祥子; 牛島知之; 牛島知之; 赤木由人; 鳥村拓司
日本消化器病学会雑誌(Web), 2021 - 切除不能進行胃癌患者に対するニボルマブ療法における免疫関連有害事象と予後の関連
田中俊光; 田中俊光; 長主祥子; 長主祥子; 牛島知之; 牛島知之; 赤木由人; 鳥村拓司; 三輪啓介; 三輪啓介
日本癌治療学会学術集会(Web), 2021 - 肝細胞癌に対するレンバチニブ治療のバイオマーカー探索および耐性獲得に関与するIGFBP-1についての検討
鈴木浩之; 岩本英希; 中村徹; 増田篤高; 阪上尊彦; 田中俊光; 中野暖; 新関敬; 中野聖士; 岡村修祐; 下瀬茂男; 城野智毅; 野田悠; 蒲池直紀; 黒松亮子; 古賀浩徳; 鳥村拓司
肝臓, 2021 - 化学療法中に発症したトルソー症候群8例の検討
田中俊光; 田中俊光; 蒲池直紀; 蒲池直紀; 長主祥子; 長主祥子; 深堀理; 深堀理; 牛島知之; 牛島知之; 赤木由人; 鳥村拓司; 三輪啓介; 三輪啓介
日本癌治療学会学術集会(Web), 2020 - 化学療法中に発症したトルソー症候群5例の検討
田中俊光; 田中俊光; 重藤宏太; 重藤宏太; 長主祥子; 長主祥子; 深堀理; 深堀理; 牛島知之; 牛島知之; 古賀浩徳; 赤木由人; 鳥村拓司; 三輪啓介; 三輪啓介
日本臨床腫瘍学会学術集会(CD-ROM), 2019 - 皮下埋め込み式中心静脈アクセスポートの安全性に関する検討
田中俊光; 田中俊光; 最初公平; 下津浦康隆; 下津浦康隆; 長主祥子; 長主祥子; 深堀理; 深堀理; 牛島知之; 牛島知之; 古賀浩徳; 赤木由人; 鳥村拓司; 三輪啓介; 三輪啓介
日本臨床腫瘍学会学術集会(CD-ROM), 2018 - 皮下埋め込み式中心静脈アクセスポート関連の合併症とベバシズマブとの関連性
田中俊光; 田中俊光; 下津浦康隆; 下津浦康隆; 長主祥子; 長主祥子; 深堀理; 深堀理; 牛島知之; 牛島知之; 赤木由人; 鳥村拓司; 三輪啓介; 三輪啓介
日本癌治療学会学術集会(Web), 2018 - mFOLFOX6+Panitumumab療法中に高アンモニア血症を伴う意識障害を発症した進行大腸癌の一例
田中俊光; 田中俊光; 三輪啓介; 三輪啓介; 四方田隆任; 阪上尊彦; 長主祥子; 深堀理; 深堀理; 牛島知之; 古賀浩徳; 鳥村拓司
日本臨床腫瘍学会学術集会(CD-ROM), 2017
- 進行胃癌における肥満パラドックスのレプチンを介した分子機構の解明
久留米大学病院
Jan. 2025 - Jan. 2027 - Anti-PD-L1 antibodies promote cellular proliferation by activating the PD-L1-AXL signal relay in liver cancer cells
Michel Impact Factor Immunology Award
Apr. 2025 - Mar. 2026 - Establishment of a treatment for hepatocellular carcinoma by applying cell cycle-dependent PD-L1 and Fas/CD95 expression changes
Grant-in-Aid for Early-Career Scientists
Kurume University
01 Apr. 2019 - 31 Mar. 2022
